[HTML][HTML] Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats
D Vallöf, AL Kalafateli, E Jerlhag - Translational psychiatry, 2020 - nature.com
Given the limited efficacy of available pharmacotherapies for treatment of alcohol use
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats.
D Vallöf, AL Kalafateli, E Jerlhag - Translational Psychiatry, 2020 - europepmc.org
Given the limited efficacy of available pharmacotherapies for treatment of alcohol use
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats
D Vallöf, AL Kalafateli, J Elisabet - Translational Psychiatry, 2020 - search.proquest.com
Given the limited efficacy of available pharmacotherapies for treatment of alcohol use
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats.
D Vallöf, AL Kalafateli, E Jerlhag - Translational Psychiatry, 2020 - search.ebscohost.com
Given the limited efficacy of available pharmacotherapies for treatment of alcohol use
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats
D Vallöf, AL Kalafateli… - Translational psychiatry, 2020 - pubmed.ncbi.nlm.nih.gov
Given the limited efficacy of available pharmacotherapies for treatment of alcohol use
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
[PDF][PDF] Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats
D Vallöf, AL Kalafateli, E Jerlhag - 2020 - scholar.archive.org
Given the limited efficacy of available pharmacotherapies for treatment of alcohol use
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
[HTML][HTML] Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats
D Vallöf, AL Kalafateli, E Jerlhag - Translational Psychiatry, 2020 - ncbi.nlm.nih.gov
Given the limited efficacy of available pharmacotherapies for treatment of alcohol use
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats
D Vallöf, AL Kalafateli, J Elisabet - Translational Psychiatry, 2020 - search.proquest.com
Given the limited efficacy of available pharmacotherapies for treatment of alcohol use
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats.
D Vallöf, AL Kalafateli, E Jerlhag - Translational Psychiatry, 2020 - europepmc.org
Given the limited efficacy of available pharmacotherapies for treatment of alcohol use
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …
disorder (AUD), the need for new medications is substantial. Preclinical studies have shown …